August 20, 2024
by Marla Paul, Northwestern University
Credit: CC0 Public Domain
Just as your primary care physician offers routine blood tests to gauge cholesterol or glucose levels, they might soon offer a blood test to diagnose Alzheimer’s disease.
Two papers presented recently at the Alzheimer’s Association International Conference (AAIC 2024) add to growing evidence of the test’s reliability. One study showed the diagnostic accuracy of the test in a primary care setting when compared to the gold standard of a spinal fluid test. The other showed the test was reliable for diagnosing Alzheimer’s in presymptomatic stages where people don’t yet have cognitive impairment.
Northwestern Now recently spoke with Dr. Joshua Cahan, a Northwestern Medicine neurologist and assistant professor of neurology at Northwestern Feinberg School of Medicine who is investigating Alzheimer’s prevention therapies, to find out who should take the blood test and why.
Is the Alzheimer’s blood test truly reliable?
We’ve known they’ve been reliable for a few years. As time goes on, more evidence is accumulating that they are useful. The new papers presented last week and published in JAMA Neurology and JAMA suggest one biomarker, P-Tau 217, is able to predict and diagnose the disease.
This biomarker is specific to Alzheimer’s disease but cannot rule out other causes of cognitive decline. P-Tau 217 can also be abnormal in people without symptoms of cognitive decline. I am optimistic about the prospects of the test, but there are nuances to the interpretation that need to be worked out. Experts are still debating the exact role it will play in clinical practice.
Should I get the test if I’ve been feeling forgetful?
The test can’t replace a thorough history and cognitive exam with a cognitive care specialist. Now biomarker testing is only recommended by the Alzheimer’s Association for people with symptoms of cognitive impairment.
There are several caveats to getting this test in a primary care setting. Insurance is not typically covering these blood tests. Also, the results can be borderline, and a primary care doctor may not know how to interpret the information. Given the weight of the diagnosis, a primary care office would need to be comfortable setting aside an appropriate amount of time to give this diagnosis and be prepared to answer all the questions, if the result is positive.
It is important for people to recognize that forgetting is part of daily life and only a detailed history and exam can help differentiate whether memory complaints are normal or abnormal.
If the test is negative, am I in the clear for a cognitive disease?
People should be aware there are other reasons for cognitive impairment besides this disease. Other possibilities are frontotemporal dementia, strokes, Lewy body dementia, thyroid disease and vitamin deficiencies. There is other diagnostic work that should be done before an Alzheimer’s test is ordered.
More information: Shorena Janelidze et al, Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment, JAMA Neurology (2024). DOI: 10.1001/jamaneurol.2024.2619
Sebastian Palmqvist et al, Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care, JAMA (2024). DOI: 10.1001/jama.2024.13855
Journal information: Journal of the American Medical Association , Archives of Neurology
Provided by Northwestern University
Leave a Reply